Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DuraStat is a private U.S. medical device company focused on surgical tissue closure technologies for spine and other soft-tissue procedures. Its flagship DuraStat device is designed for dural repair during spine surgery, helping surgeons place sutures more efficiently and with less wrist rotation in difficult-access settings. The company has also developed TissueStat for minimally invasive fascial closure and broader soft-tissue approximation. DuraStat markets clinically oriented, procedure-specific devices rather than therapeutics, and its products are already distributed commercially in the United States. The company has partnered commercially with Medtronic to expand U.S. reach within cranial and spinal technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DuraStat.